SCHEMBL28247405

SCHEMBL28247405

Nc1nc(Nc2cccc(S(N)(=O)=O)c2)ncc1-c1ccc(Cn2ccnc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 10/20 0.51
▸ CDK2 P24941 8/20 0.51
▸ CDK5 Q00535 5/20 0.51
▸ JAK3 P52333 5/20 0.51
▸ EGFR P00533 4/20 0.51
▸ NTRK1 P04629 3/20 0.51
▸ AURKA O14965 3/20 0.51
▸ DCLK1 O15075 3/20 0.51
▸ AURKB Q96GD4 3/20 0.51
▸ PDPK1 O15530 2/20 0.51
▸ JAK2 O60674 2/20 0.51
▸ ROCK2 O75116 2/20 0.51
▸ PRKD3 O94806 2/20 0.51
▸ MAP4K4 O95819 2/20 0.51
▸ PRKCG P05129 2/20 0.51
▸ LCK P06239 2/20 0.51
▸ FYN P06241 2/20 0.51
▸ LYN P07948 2/20 0.51
▸ RET P07949 2/20 0.51
▸ IGF1R P08069 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28059048 0.83 CDK1 (0.50) CDK1CDK2CDK5JAK3EGFR
Hydrochloric Acid SCHEMBL28247591 0.83 CDK1 (0.49) CDK1CDK2CDK5JAK3EGFR
SCHEMBL4000383 0.82 EGFR (0.68) CDK1CDK2CDK5JAK3EGFR
SCHEMBL28246650 0.80 CDK2 (0.47) CDK1CDK2CDK5JAK3EGFR
SCHEMBL28247410 0.80 CDK1 (0.51) CDK1CDK2CDK5JAK3EGFR
SCHEMBL28956762 0.79 CDK2 (0.49) CDK1CDK2CDK5JAK3EGFR
SCHEMBL28246722 0.79 CDK1 (0.50) CDK1CDK2CDK5JAK3EGFR
SCHEMBL28865244 0.77 CDK1 (0.47) CDK1CDK2CDK5JAK3EGFR
SCHEMBL28247414 0.75 CDK1 (0.46) CDK1CDK2CDK5JAK3EGFR
SCHEMBL28865198 0.73 CDK1 (0.50) CDK1CDK2KDRGSK3BCCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105348203-B Inhibit the composition and method of JAK approach 里格尔药品股份有限公司 2018-09-18 — — CN disclosed
Send feedback